X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (52152) 52152
Book Review (9796) 9796
Publication (3614) 3614
Newspaper Article (2439) 2439
Newsletter (645) 645
Book Chapter (404) 404
Book / eBook (183) 183
Conference Proceeding (110) 110
Magazine Article (96) 96
Trade Publication Article (84) 84
Web Resource (64) 64
Dissertation (60) 60
Report (15) 15
Reference (6) 6
Transcript (6) 6
Data Set (5) 5
Government Document (4) 4
Paper (3) 3
Journal / eJournal (2) 2
Presentation (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42013) 42013
humans (41696) 41696
male (22415) 22415
female (21480) 21480
hematology (20716) 20716
oncology (20665) 20665
leukemia (19325) 19325
adult (16179) 16179
middle aged (15810) 15810
cancer (12268) 12268
aged (11865) 11865
acute myeloid-leukemia (9847) 9847
adolescent (9748) 9748
child (7955) 7955
prognosis (7899) 7899
chemotherapy (7095) 7095
research (6419) 6419
acute myeloid leukemia (5923) 5923
transplantation (5725) 5725
child, preschool (5459) 5459
acute lymphoblastic-leukemia (5225) 5225
treatment outcome (5005) 5005
care and treatment (4971) 4971
leukemia, myeloid, acute - genetics (4820) 4820
mutation (4801) 4801
diagnosis (4701) 4701
analysis (4625) 4625
stem cells (4590) 4590
risk factors (4562) 4562
bone marrow (4523) 4523
health aspects (4496) 4496
aged, 80 and over (4460) 4460
young adult (4376) 4376
genetic aspects (4194) 4194
acute disease (4183) 4183
infant (4010) 4010
leukemia, myeloid, acute - diagnosis (3837) 3837
animals (3731) 3731
retrospective studies (3644) 3644
abridged index medicus (3614) 3614
medicine & public health (3604) 3604
acute myelogenous leukemia (3574) 3574
immunology (3553) 3553
children (3532) 3532
leukemia, myeloid, acute - drug therapy (3414) 3414
expression (3329) 3329
patients (3311) 3311
therapy (3309) 3309
hematology, oncology and palliative medicine (3297) 3297
antineoplastic combined chemotherapy protocols - therapeutic use (3288) 3288
leukemia, myeloid, acute - pathology (3255) 3255
gene expression (3191) 3191
pediatrics (3189) 3189
hematopoietic stem cells (3081) 3081
hemic and lymphatic diseases (3066) 3066
antineoplastic agents - therapeutic use (2982) 2982
survival (2966) 2966
tumors (2849) 2849
aml (2769) 2769
bone-marrow-transplantation (2752) 2752
genetics & heredity (2744) 2744
leukemia, myeloid, acute - therapy (2715) 2715
karyotyping (2702) 2702
pathology (2665) 2665
myelodysplastic syndromes (2650) 2650
remission induction (2563) 2563
myelodysplastic syndrome (2541) 2541
apoptosis (2540) 2540
chronic myelogenous leukemia (2487) 2487
flow cytometry (2460) 2460
recurrence (2459) 2459
stem-cell transplantation (2426) 2426
transplantation, homologous (2422) 2422
article (2410) 2410
survival analysis (2352) 2352
lymphomas (2335) 2335
translocation, genetic (2297) 2297
bone marrow - pathology (2224) 2224
minimal residual disease (2210) 2210
chronic myeloid-leukemia (2199) 2199
classification (2199) 2199
cytogenetics (2189) 2189
hematopoietic stem cell transplantation (2188) 2188
medical research (2166) 2166
survival rate (2166) 2166
leukemia, myeloid, acute - mortality (2139) 2139
follow-up studies (2133) 2133
cells (2128) 2128
disease-free survival (2128) 2128
chromosome aberrations (2127) 2127
genes (2122) 2122
risk (2078) 2078
immunophenotyping (2053) 2053
diagnosis, differential (2021) 2021
cell biology (1987) 1987
medicine (1976) 1976
mortality (1956) 1956
myeloid leukemia (1952) 1952
proteins (1949) 1949
chronic myeloid leukemia (1947) 1947
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (123) 123
Online Resources - Online (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Scarborough Hospital - Online (2) 2
UTL at Downsview - May be requested (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
OISE - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (53853) 53853
German (439) 439
French (335) 335
Japanese (308) 308
Chinese (272) 272
Spanish (216) 216
Russian (188) 188
Polish (100) 100
Korean (63) 63
Portuguese (53) 53
Italian (48) 48
Czech (28) 28
Turkish (26) 26
Hungarian (25) 25
Danish (19) 19
Dutch (18) 18
Serbian (15) 15
Croatian (14) 14
Norwegian (9) 9
Swedish (9) 9
Bulgarian (7) 7
Romanian (7) 7
Slovak (5) 5
Slovenian (4) 4
Hebrew (3) 3
Persian (3) 3
Ukrainian (3) 3
Bosnian (2) 2
Afrikaans (1) 1
Finnish (1) 1
Hindi (1) 1
Indonesian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 02/2015, Volume 125, Issue 9, pp. 1367 - 1376
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 506, Issue 7488, pp. 328 - 333
In acute myeloid leukaemia (AML), the cell of origin, nature and biological consequences of initiating lesions, and order of subsequent mutations remain poorly... 
BREAST-CANCER | RELAPSE | ACUTE NONLYMPHOCYTIC LEUKEMIA | MULTIDISCIPLINARY SCIENCES | ACUTE LYMPHOBLASTIC-LEUKEMIA | PANCREATIC-CANCER | DNA METHYLTRANSFERASE | CLONAL EVOLUTION | ACUTE MYELOID-LEUKEMIA | DNMT3A MUTATIONS | MYELODYSPLASTIC SYNDROMES | Clone Cells - cytology | Neoplasm Transplantation | Neoplastic Stem Cells - cytology | Neoplastic Stem Cells - drug effects | Humans | Hematopoietic Stem Cells - pathology | DNA (Cytosine-5-)-Methyltransferases - metabolism | Heterografts | Neoplastic Stem Cells - metabolism | T-Lymphocytes - metabolism | Hematopoiesis | Cell Division | Leukemia, Myeloid, Acute - drug therapy | Neoplastic Stem Cells - pathology | Female | Cell Differentiation | T-Lymphocytes - pathology | Nuclear Proteins - genetics | Hematopoietic Stem Cells - drug effects | Leukemia, Myeloid, Acute - pathology | Isocitrate Dehydrogenase - genetics | Hematopoietic Stem Cells - metabolism | Mice, SCID | Mutation - genetics | Clone Cells - metabolism | Remission Induction | Cell Lineage | DNA (Cytosine-5-)-Methyltransferases - genetics | Animals | Clone Cells - pathology | Leukemia, Myeloid, Acute - diagnosis | Hematopoietic Stem Cells - cytology | Mice, Inbred NOD | Mice | Drug Resistance, Neoplasm - drug effects | Leukemia, Myeloid, Acute - genetics | Acute leukemia | Genetic aspects | Diagnosis | Identification and classification | Hematopoietic stem cells | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 31, pp. 3889 - +
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 122, Issue 1, pp. 100 - 108
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2012, Volume 30, Issue 29, pp. 3604 - 3610
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer | Index Medicus
Journal Article